Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant subunit dengue virus vaccine

Recombinant subunit dengue virus vaccine

US Patent 10137187 · Granted Nov 27, 2018

Estimated economic value: $94,550,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Laser-assisted repositioning of a micro-object and culturing of an attachment-de2025
RSV RNA vaccines2025
Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-2025
Stabilized RSV F proteins and uses thereof2025
Processes for obtaining microbial oil from microbial cells2024
RSV RNA vaccines2024
Herpes simplex virus vaccine2023
HPV vaccine2023
Stabilized RSV F proteins and uses thereof2023
Respiratory syncytial virus vaccine2022
Lipid nanoparticle vaccine adjuvants and antigen delivery systems2022
Lipid nanoparticle vaccine adjuvants and antigen delivery systems2020